SCOTCH PLAINS, N.J.--(BUSINESS WIRE)--Feb. 15, 2006--Stem Cell Innovations, Inc. (IFSC.OB), formerly known as Interferon Sciences, Inc., and Amphioxus Cell Technologies, Inc., a privately held company, today announced the merger of the two companies, a new management team, the completion of an approximately $3.8 million private placement, and certain debt exchanges. Amphioxus had acquired all of the assets of Plurion, Inc. immediately prior to the merger. The merged entity will continue the businesses of Amphioxus and Plurion, focusing on cell biology.
